Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

The document concludes that there is no agreed-upon best method for measuring drug delivery within hair follicles and more research is needed to validate current techniques.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Hair follicle stem cells and skin cells show promise for hair and skin therapies but need more research for clinical use.

Hairless protein is crucial for healthy skin and hair, and its malfunction can cause hair loss.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Three white adults had a rare scalp condition with increased fat and sometimes hair loss, suggesting it's not limited to black women and might be more widespread.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Immune cells affect hair growth and could lead to new hair loss treatments.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

Using neurohormones to control keratin can lead to new skin disease treatments.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

Loose Anagen Syndrome causes easy-to-pull, thin hair, mainly in young girls, and improves with age.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Gene network oscillations inside hair stem cells are key for hair growth regulation and could help treat hair loss.